Pediatric Multicenter Study of REPEL-CV

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by SyntheMed.
Recruitment status was  Recruiting
Information provided by:
SyntheMed Identifier:
First received: June 27, 2005
Last updated: NA
Last verified: June 2005
History: No changes posted
This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.

Condition Intervention Phase
Device: REPEL-CV
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Peds. Multicenter Study

Resource links provided by NLM:

Further study details as provided by SyntheMed:

Detailed Description:
- Efficacy at second sternotomy

Ages Eligible for Study:   up to 1 Year
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Stage sternotomies

Exclusion Criteria:

  • Delayed closure beyond 5 days
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00116233

Contact: Eli Pines, Ph.D. 212-460-9488

United States, New Jersey
SyntheMed Recruiting
Little Silver, New Jersey, United States, 07739
Contact: Eli Pines, Ph.D.    212-460-9488      
Sponsors and Collaborators
Study Director: Eli Pines SyntheMed
  More Information

No publications provided Identifier: NCT00116233     History of Changes
Other Study ID Numbers: LMS0104RCV
Study First Received: June 27, 2005
Last Updated: June 27, 2005
Health Authority: United States: Food and Drug Administration

Keywords provided by SyntheMed:
post operative adhesions processed this record on November 27, 2015